Biological and Medicinal Properties of Chrysanthemum boreale Makino and Its Bioactive Products
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26135956 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Christian Bailly. Beteiligte Einrichtung: UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, CHU Lille, CNRS, Inserm, OncoLille Institut, University of Lille, …. Hauptthemen laut MEDLINE: Chrysanthemum, Plant Extracts, Biological Products. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 194 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Chrysanthemum species represent an economically important group of flowering plants. Many species also present a medicinal interest, notably for the treatment of inflammatory pathologies. This is the case for Chrysanthemum boreale Makino, endemic to Japan and widespread in Eastern Asia. This perennial plant has long been used in folk medicine to treat inflammatory diseases and bacterial infections. An extensive review of the scientific literature pertaining to C. boreale has been performed to analyze the origin of the plant, its genetic traits, the traditional usages, and the properties of aqueous or organic plant extracts and essential oils derived from this species. Aqueous extracts and the associated flavonoids, such as acacetin and glycoside derivatives, display potent antioxidant activities. These aqueous extracts and floral waters are used mainly as cytoprotective agents. Organic extracts, in particular those made from methanol or ethanol, essentially display antioxidant and anti-inflammatory properties useful to protect organs from oxidative damage. They can be used for neuroprotection. Essential oils from C. boreale have been used as cytoprotective or antibacterial agents. The main bioactive natural products isolated from the plant include flavonoids such as acacetin and related glycosides (notably linarin), and diverse sesquiterpene lactones (SLs). Among monomeric SLs, cumambrins and borenolide are the main products of interest, with cumambrin A targeting covalently the transcription factor NF-κB to regulate proinflammatory gene expression to limit osteoclastic bone resorption. The dimeric SL handelin, which is characteristic of C. boreale, exhibits a prominent anti-inflammatory action, with a capacity to target key proteins like kinase TAK1 and chaperone Hsp70. A few other natural products isolated from the plant (tulipinolide, polyacetylenic derivatives) are discussed. Altogether, the review explores all medicinal usages of the plant and the associated phytochemical panorama, with the objective of promoting further botanical and chemical studies of this ancestral medicinal species.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, CHU Lille, CNRS, Inserm, OncoLille Institut, University of Lille, 59000 Lille, France.
- Institute of Pharmaceutical Chemistry Albert Lespagnol (ICPAL), Faculty of Pharmacy, University of Lille, 59006 Lille, France.
- OncoWitan, Scientific Consulting Office, 59290 Lille, France.
ORCID-Profile: Christian Bailly
Zitieren
APA
Bailly, C. (2025). Biological and Medicinal Properties of Chrysanthemum boreale Makino and Its Bioactive Products. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26135956
Vancouver
Bailly C. Biological and Medicinal Properties of Chrysanthemum boreale Makino and Its Bioactive Products. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26135956
BibTeX
@article{Bailly2025,
author = {Bailly, Christian},
title = {Biological and Medicinal Properties of Chrysanthemum boreale Makino and Its Bioactive Products},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26135956}
}
EUVIMED